Jeff Evanson - 31 Mar 2022 Form 4 Insider Report for Outlook Therapeutics, Inc. (OTLK)

Role: Chief Commercial Officer
Signature: /s/ Lawrence Kenyon, Attorney-in-Fact
Issuer symbol: OTLK
Transactions as of: 31 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 04 Apr 2022, 18:47:27 UTC
Previous filing: 23 Dec 2021
Next filing: 19 Jan 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OTLK	Stock Option (Right to Buy)	Award	$0	+100,000		$0.000000	100,000	31 Mar 2022	Common Stock	100,000	$1.44	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares that vested under a performance-based stock option grant based on the Issuer's satisfaction of certain performance criteria. In light of the performance-based vesting conditions of the option, such shares were not reportable under Section 16 until vesting was determined, which occurred on March 31, 2022. The vested shares represents the first of three possible vesting events of the total number of shares subject to the option. The remaining shares subject to the option will vest only upon the satisfaction of additional performance vesting criteria.
F2	Fully vested and immediately exercisable.

Content

Represents the number of shares that vested under a performance-based stock option grant based on the Issuer's satisfaction of certain performance criteria. In light of the performance-based vesting conditions of the option, such shares were not reportable under Section 16 until vesting was determined, which occurred on March 31, 2022. The vested shares represents the first of three possible vesting events of the total number of shares subject to the option. The remaining shares subject to the option will vest only upon the satisfaction of additional performance vesting criteria.

Fully vested and immediately exercisable.